Dylan Grassie

Research Associate
Drug Discovery Department

Phone: (813) 745-8297

Email: dylan.grassie@moffitt.org


 BS in Chemistry - University of South Florida, Tampa, Florida, 2017


  • Giuliano AR, Pilon-Thomas S, Schell MJ, Abrahamsen M, Islam JY, Isaacs-Soriano K, Kennedy K, Dukes CW, Whiting J, Rathwell J, Hensel JA, Mangual LN, Schonbrunn E, Bikowitz M, Grassie D, Yang Y. SARS-CoV-2 Period Seroprevalence and Related Factors, Hillsborough County, Florida, USA, October 2020-March 2021. Emerg Infect Dis. 2022 Mar;28(3):556-563. doi: 10.3201/eid2803.211495. Epub 2022 Jan 26. PMID: 35081021; PMCID: PMC8888241.
  • Karim RM, Yang L, Chen L, Bikowitz MJ, Lu J, Grassie D, Shultz ZP, Lopchuk JM, Chen J, Schönbrunn E. Discovery of Dual TAF1-ATR Inhibitors and Ligand-Induced Structural Changes of the TAF1 Tandem Bromodomain. J Med Chem. 2022 Mar 10;65(5):4182-4200. doi: 10.1021/acs.jmedchem.1c01999. Epub 2022 Feb 22. PMID: 35191694.
  • Karim RM, Bikowitz MJ, Chan A, Zhu JY, Grassie D, Becker A, Berndt N, Gunawan S, Lawrence NJ, Schönbrunn E. Differential BET Bromodomain Inhibition by Dihydropteridinone and Pyrimidodiazepinone Kinase Inhibitors. J Med Chem. 2021 Nov 11;64(21):15772-15786. doi: 10.1021/acs.jmedchem.1c01096. Epub 2021 Oct 28. PMID: 34710325.